[Home ] [Archive]    
:: Home :: About Journal :: Registration :: Article Submission :: Contact us :: Site Map ::
:: Volume 5, Issue 1 (Autumn 2012) ::
IJBC 2012, 5(1): 25-28 Back to browse issues page
A Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient
Soumaya Anoun *, Mouna Lamchahab, Meriem Qachouh, Said Benchekroun, Asmae Quessar
Abstract:   (5489 Views)
Methotrexate is an anti-rheumatic agent used as a first-line tretment for rheumatoid arthritis. Hematological malignancies like lymphoma or acute myeloid leukemia have been reported to be secondary to treatment with Methotrexate, but are very uncommon. We report here the first Moroccan case of RA patient on low dose MTX, who developed AML. We also reviewed all similar cases.
Full-Text [PDF 406 kb]   (2181 Downloads)    
: Research | Subject: Methodology
Received: 2012/04/10 | Accepted: 2012/07/18 | Published: 2013/05/30
Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Anoun S, Lamchahab M, Qachouh M, Benchekroun S, Quessar A. A Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient. IJBC. 2012; 5 (1) :25-28
URL: http://ijbc.ir/article-1-397-en.html


Volume 5, Issue 1 (Autumn 2012) Back to browse issues page
مجله ی خون و سرطان ایران Iranian Journal of Blood and Cancer
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 3991